CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in R&D expenditure
4.1.2. Rapid growth in biopharmaceutical & biotechnology industries
4.1.3. Increasing government support in the form of funds and contracts
4.1.4. Adoption of single-use technologies
4.1.5. Increase in therapeutics contamination by viruses
4.2. Market Restraints & Challenges
4.2.1. Highly consolidated market
4.2.2. Strict regulations for filtration product validation
4.3. Market Opportunities
4.3.1. Increasing pharmaceutical outsourcing & emerging economies
CHAPTER 5. GLOBAL VIRUS FILTRATION MARKET– BY PRODUCT
5.1. Kits & Reagents
5.2. Filtration Systems
5.3. Services
5.4. Others
CHAPTER 6. GLOBAL VIRUS FILTRATION MARKET – BY APPLICATION
6.1. Vaccines and Therapeutics
6.2. Blood and Blood Products
6.3. Cellular and Gene Therapy Products
6.4. Tissue and Tissue Products
6.5. Stem Cell Products
6.6. Medical Devices
6.7. Water Purification
6.8. Air Purification
CHAPTER 7. GLOBAL VIRUS FILTRATION MARKET – BY END USER
7.1. Biopharmaceutical & Biotechnology Companies
7.2. Research Laboratories and Institutes
7.3. CROs
7.4. Medical Device Companies
CHAPTER 8. GLOBAL VIRUS FILTRATION MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL VIRUS FILTRATION MARKET - COMPANY PROFILES
9.1. Lonza Group
9.2. SGS S.A.
9.3. Sigma-Aldrich Corporation
9.4. Charles River Laboratories International, Inc.
9.5. BSL Bioservice
9.6. Merck KGaA
9.7. Avance Biosciences Inc.
9.8. Texcell, Inc.
9.9. Clean Cells, Inc.
9.10. Wuxi Pharmatech (CAYMAN) Inc.
9.11. F- Hoffmann-La Roche Ltd
9.12. Pfizer, Inc.
9.13. Illumina, Inc.
9.14. Promocell GmbH
9.15. Eppendorf AG
CHAPTER 10. GLOBAL VIRUS FILTRATION MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
